Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers—A mini‐review

Lung carcinoma is one of the most common causes of cancer‐related mortality worldwide. It is an aggressive tumor, often diagnosed at an advanced stage when treatment options are limited. Currently, the importance of detection and assessment of various genetic alterations in cancer is recognized as they can serve as very helpful markers in early diagnosis and follow‐up of treatment regimens. Recently, several therapeutically important genetic markers have been identified. One major problem is that tumor tissue specimens used to assay these genetic biomarkers are not always available, especially in the early stages of the disease. Therefore, exhaled breath condensates (EBC) could represent a good non‐invasive source to allow the evaluation of these important genetic markers; these could help in the diagnosis, follow‐up of the disease and/or assessment of treatment efficacy. The key aims of this review are first to describe the origin and constituents of EBC, as well as the different methodological procedures used in studying EBC biomarkers, and second, to document genetic and epigenetic markers that have been analyzed in EBC from lung cancer patients and to estimate their diagnostic and prognostic value. © 2016 Wiley Periodicals, Inc.

[1]  G. E. Carpagnano,et al.  Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases , 2016, Journal of breath research.

[2]  Jianrong Chen,et al.  Analysis of p16 gene mutations and their expression using exhaled breath condensate in non-small-cell lung cancer. , 2015, Oncology letters.

[3]  J. C. Jongste,et al.  The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children – clinical tools or scientific toys? , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  S. Knuutila,et al.  Driver Gene Mutations of Non-Small-Cell Lung Cancer are Rare in Primary Carcinoids of the Lung: NGS Study by Ion Torrent , 2015, Lung.

[5]  I. Williamson,et al.  The complexity and difficulty of diagnosing lung cancer: findings from a national primary-care study in Wales , 2014, Primary Health Care Research & Development.

[6]  A. Shaw,et al.  ALK inhibitors in non-small cell lung cancer: crizotinib and beyond. , 2014, Clinical advances in hematology & oncology : H&O.

[7]  Y. Ishikawa,et al.  Combined effects of asbestos and cigarette smoke on the development of lung adenocarcinoma: Different carcinogens may cause different genomic changes , 2014, Oncology reports.

[8]  Cristina E. Davis,et al.  Analysis of Volatile Compounds in Exhaled Breath Condensate in Patients with Severe Pulmonary Arterial Hypertension , 2014, PloS one.

[9]  O. Araneda,et al.  Increase of pro-oxidants with no evidence of lipid peroxidation in exhaled breath condensate after a 10-km race in non-athletes , 2014, Journal of Physiology and Biochemistry.

[10]  K. Olsen,et al.  Occupational Asbestos Exposure and Lung Cancer—A Systematic Review of the Literature , 2014, Archives of environmental & occupational health.

[11]  Hans Kromhout,et al.  Occupational Asbestos Exposure and Risk of Pleural Mesothelioma, Lung Cancer, and Laryngeal Cancer in the Prospective Netherlands Cohort Study , 2014, Journal of occupational and environmental medicine.

[12]  A. Casalini,et al.  Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[13]  A. August,et al.  Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. , 2013, The Journal of allergy and clinical immunology.

[14]  P. Thomas,et al.  Exhaled breath condensate: a comprehensive update , 2013, Clinical chemistry and laboratory medicine.

[15]  R. Lodha,et al.  Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases. , 2013, The Journal of allergy and clinical immunology.

[16]  P. Thomas,et al.  Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. , 2013, Respiratory medicine.

[17]  D. Aberle,et al.  Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Lin,et al.  Reply to comment on 'The effect of temperature on exhaled breath condensate collection' , 2012, Journal of breath research.

[19]  J. Szemraj,et al.  Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene. , 2012, Respiratory medicine.

[20]  Alison J. Montpetit,et al.  Exhaled breath condensate: an overview. , 2007, Immunology and allergy clinics of North America.

[21]  G. E. Carpagnano,et al.  Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion? , 2012, Rejuvenation research.

[22]  H. Koskela,et al.  Asthmatic cough and airway oxidative stress , 2012, Respiratory Physiology & Neurobiology.

[23]  E. Kovacs,et al.  Exhaled breath condensate collection in the mechanically ventilated patient. , 2012, Respiratory medicine.

[24]  T. Greulich,et al.  Comparison of Two Devices and Two Breathing Patterns for Exhaled Breath Condensate Sampling , 2011, PloS one.

[25]  K. Kiura,et al.  Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung. , 2011, Lung cancer.

[26]  G. E. Carpagnano,et al.  HPV in exhaled breath condensate of lung cancer patients , 2011, British Journal of Cancer.

[27]  P. Thomas,et al.  Standardization of exhaled breath condensate: effects of different de-aeration protocols on pH and H2O2 concentrations , 2011, Journal of breath research.

[28]  D. Wakefield,et al.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques , 2011, Inflammopharmacology.

[29]  T. Brüning,et al.  Increased metal concentrations in exhaled breath condensate of industrial welders. , 2011, Journal of environmental monitoring : JEM.

[30]  D. Yates,et al.  Breath analysis in asbestos-related disorders: a review of the literature and potential future applications , 2010, Journal of breath research.

[31]  G. E. Carpagnano,et al.  Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients. , 2010, Lung cancer.

[32]  Q. Jöbsis,et al.  Feasibility of a new method to collect exhaled breath condensate in pre‐school children , 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[33]  A. A. Reilly,et al.  Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients , 2009, Respiratory research.

[34]  A. Spanevello,et al.  Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. , 2009, Lung cancer.

[35]  D. Rea,et al.  Role of tyrosine kinase inhibitors in lung cancer. , 2009, Anti-cancer agents in medicinal chemistry.

[36]  T. Bengtsson,et al.  Exhaled breath condensate—site and mechanisms of formation , 2009, Journal of breath research.

[37]  L. Nordvall,et al.  Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis. , 2009, Respiratory medicine.

[38]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[39]  Z. Borrill,et al.  Exhaled breath condensate biomarkers in COPD , 2008, European Respiratory Journal.

[40]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[41]  Ildikó Horváth,et al.  Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. , 2008, Respiratory medicine.

[42]  Q. Jöbsis,et al.  Biomarker reproducibility in exhaled breath condensate collected with different condensers , 2008, European Respiratory Journal.

[43]  R. Matran,et al.  Cytokine concentrations in exhaled breath condensates in systemic sclerosis , 2008, Inflammation Research.

[44]  A. Paradiso,et al.  3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. , 2008, American journal of respiratory and critical care medicine.

[45]  U. Range,et al.  Exhaled breath condensate pH in infants and children with acute and recurrent wheezy bronchitis , 2007, Pediatric pulmonology.

[46]  A Mutti,et al.  Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults , 2007, European Respiratory Journal.

[47]  D. Yates,et al.  Collection devices influence the constituents of exhaled breath condensate , 2007, European Respiratory Journal.

[48]  J. Jen,et al.  Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer. , 2007, Mitochondrion.

[49]  Sten Orrenius,et al.  Mitochondria, oxidative stress and cell death , 2007, Apoptosis.

[50]  D. Yates,et al.  Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. , 2007, American journal of respiratory and critical care medicine.

[51]  R. Guleria,et al.  Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. , 2006, Clinical chemistry.

[52]  O. Kalayci,et al.  Comparison of two methods for exhaled breath condensate collection , 2006, Allergy.

[53]  P. Apostoli,et al.  Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. , 2006, Chest.

[54]  F. Emmrich,et al.  Multiplex analysis of cytokines in exhaled breath condensate , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[55]  S. Stick,et al.  Measuring Exhaled Breath Condensates in Infants , 2006, Pediatric pulmonology.

[56]  P. Montuschi,et al.  Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD , 2005, Thorax.

[57]  A. Paradiso,et al.  3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. , 2005, American journal of respiratory and critical care medicine.

[58]  M. Corradi,et al.  Influence of condensation temperature on selected exhaled breath parameters , 2005, BMC pulmonary medicine.

[59]  P. J. Barnes,et al.  Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.

[60]  A. Maitra,et al.  Mitochondrial DNA as a cancer biomarker. , 2005, The Journal of molecular diagnostics : JMD.

[61]  M. Corradi,et al.  Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. , 2005, The Journal of allergy and clinical immunology.

[62]  S. Ohta,et al.  Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. , 2005, Cancer research.

[63]  H. Kuhn,et al.  Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. , 2004, Lung cancer.

[64]  Q. Jöbsis,et al.  Exhaled breath condensate in children: Pearls and pitfalls , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[65]  A Smith,et al.  Exhaled breath condensate pH is a robust and reproducible assay of airway acidity , 2003, European Respiratory Journal.

[66]  S. Toyooka,et al.  Alterations in the mitochondrial displacement loop in lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  P. Montuschi,et al.  CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease , 2003, Thorax.

[68]  Mitsuhiro Osame,et al.  Mitochondrial DNA mutation correlates with stage progression and prognosis in non‐small cell lung cancer , 2003, Human mutation.

[69]  I. Horváth,et al.  Comparison of nasal and oral inhalation during exhaled breath condensate collection. , 2003, American journal of respiratory and critical care medicine.

[70]  I. Horváth,et al.  Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma , 2002, European Respiratory Journal.

[71]  M. Gare,et al.  Dilution of respiratory solutes in exhaled condensates. , 2002, American journal of respiratory and critical care medicine.

[72]  J. T. Wachsman,et al.  Mitochondrial DNA in human malignancy. , 2001, Mutation research.

[73]  H. Magnussen,et al.  The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. , 2000, The European respiratory journal.

[74]  J. Jen,et al.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.

[75]  J. Herman,et al.  Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. , 1999, Journal of the National Cancer Institute.

[76]  B. Christman,et al.  Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. , 1998, Chest.

[77]  R. Schlapbach,et al.  Oxidants in mitochondria: from physiology to diseases. , 1995, Biochimica et biophysica acta.

[78]  Ping Xiao,et al.  Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. , 2014, Lung cancer.

[79]  M. Fleischhacker,et al.  Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.

[80]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[81]  Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children — 1999 , 1999 .

[82]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[83]  M. Stroun,et al.  Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.

[84]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.